BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Zhang XS, Jin R, Zhang SB, Tao ML. Clinical features of adverse reactions associated with telbivudine. World J Gastroenterol 2008; 14(22): 3549-3553 [PMID: 18567085 DOI: 10.3748/wjg.14.3549]
URL: https://www.wjgnet.com/1007-9327/full/v14/i22/3549.htm
Number Citing Articles
1
George P. H. Leung. Advances in Mitochondrial MedicineAdvances in Experimental Medicine and Biology 2012; 942: 347 doi: 10.1007/978-94-007-2869-1_16
2
Current awareness: Pharmacoepidemiology and drug safetyPharmacoepidemiology and Drug Safety 2008; 17(12) doi: 10.1002/pds.1493
3
Won Young Tak, Soo Young Park, Chang Min Cho, Min Kyu Jung, Seong Woo Jeon, Young Oh Kweon, Ji Young Park, Yoon Kyung Sohn. Clinical, biochemical, and pathological characteristics of clevudine-associated myopathyJournal of Hepatology 2010; 53(2): 261 doi: 10.1016/j.jhep.2010.03.006
4
Ivana Carey, Phillip M Harrison. Monotherapy versus combination therapy for the treatment of chronic hepatitis BExpert Opinion on Investigational Drugs 2009; 18(11): 1655 doi: 10.1517/13543780903241599
5
Ji Won Lee, Young Jun Lee, Jong Joon Lee, Jung Ho Kim, Young Kul Jung, Oh Sang Kwon, Duck Joo Choi, Yun Soo Kim, Ju Hyun Kim. Efficacy of Entecavir Switching Therapy in Chronic Hepatitis B Patients with Clevudine-induced MyopathyThe Korean Journal of Gastroenterology 2013; 61(1): 30 doi: 10.4166/kjg.2013.61.1.30
6
Jessica A. Brown, Lindsey R. Pack, Jason D. Fowler, Zucai Suo. Presteady State Kinetic Investigation of the Incorporation of Anti-Hepatitis B Nucleotide Analogues Catalyzed by Noncanonical Human DNA PolymerasesChemical Research in Toxicology 2012; 25(1): 225 doi: 10.1021/tx200458s
7
Min-Hui Liu, Yun-Jian Sheng, Jun-Ying Liu, Huai-Dong Hu, Qiong-Fang Zhang, Hong Ren. Efficacy of telbivudine on interruption of hepatitis B virus vertical transmission: a meta-analysisAnnals of Saudi Medicine 2013; 33(2): 169 doi: 10.5144/0256-4947.2013.169
8
Byung Kook Kim, Jeeyoung Oh, So Young Kwon, Won Hyeok Choe, Soon Young Ko, Kyoung Hoon Rhee, Tae Ho Seo, So Dug Lim, Chang Hong Lee. Clevudine myopathy in patients with chronic hepatitis BJournal of Hepatology 2009; 51(4): 829 doi: 10.1016/j.jhep.2009.04.019
9
Yan Hong Wang, Ben Quan Wu, Hui Liu. Continuous venovenous hemodiafiltration for hyperlactatemia caused by telbivudine in a patient with chronic hepatitis B: A case report and update reviewJournal of Digestive Diseases 2015; 16(3): 164 doi: 10.1111/1751-2980.12173
10
J. Fung, C.-L. Lai, W.-K. Seto, M.-F. Yuen. Nucleoside/nucleotide analogues in the treatment of chronic hepatitis BJournal of Antimicrobial Chemotherapy 2011; 66(12): 2715 doi: 10.1093/jac/dkr388
11
Vandana Khungar, Steven-Huy Han. A Systematic Review of Side Effects of Nucleoside and Nucleotide Drugs Used for Treatment of Chronic Hepatitis BCurrent Hepatitis Reports 2010; 9(2): 75 doi: 10.1007/s11901-010-0039-1
12
Peter Karayiannis. Direct Acting Antivirals for the Treatment of Chronic Viral HepatitisScientifica 2012; 2012: 1 doi: 10.6064/2012/478631
13
Tianye He, Bicui Chen, Yaqun Li, Yun Song, Jian Wu, Biyu Xiong, Bin Wang, Jianfei Long. Creatine kinase elevation in chronic hepatitis B patients with telbivudine therapy: influence of telbivudine plasma concentration and single nucleotide polymorphisms of TK2, RRM2B, and NME4European Journal of Clinical Pharmacology 2024;  doi: 10.1007/s00228-024-03674-w
14
Ya-Wen Yang, Meng-Kun Tsai, Ching-Yao Yang, Chih-Yuan Lee, Bor-Luen Chiang, Hong-Shiee Lai. Telbivudine for renal transplant recipients with chronic hepatitis B infection: a randomized controlled trial with early terminationClinical and Experimental Nephrology 2020; 24(5): 474 doi: 10.1007/s10157-020-01850-7
15
Eun Hye Kim, Hana Park, Kun Ho Lee, Sang Hoon Ahn, Seung-Min Kim, Kwang-Hyub Han. Two cases of telbivudine-induced myopathy in siblings with chronic hepatitis BClinical and Molecular Hepatology 2013; 19(1): 82 doi: 10.3350/cmh.2013.19.1.82
16
Attur Ravindra Prabhu, Indu Ramachandra Rao, Shankar Prasad Nagaraju, Eti Rajwar, Bhumika T Venkatesh, Sreekumaran Nair N, Ganesh Pai, Nageswara P Reddy, Deepak Suvarna. Interventions for dialysis patients with hepatitis C virus (HCV) infectionCochrane Database of Systematic Reviews 2023; 2023(4) doi: 10.1002/14651858.CD007003.pub3
17
X. J. Zou, X. Q. Jiang, D. Y. Tian. Clinical features and risk factors of creatine kinase elevations and myopathy associated with telbivudineJournal of Viral Hepatitis 2011; 18(12): 892 doi: 10.1111/j.1365-2893.2010.01412.x
18
Avin Ramanjooloo, Raymond J Andersen, Archana Bhaw-Luximon. Marine sponge-derived/inspired drugs and their applications in drug delivery systemsFuture Medicinal Chemistry 2021; 13(5): 487 doi: 10.4155/fmc-2020-0123
19
Josef Finsterer, Leyla Ay. Myotoxicity of telbivudine in pre-existing muscle damageVirology Journal 2010; 7(1) doi: 10.1186/1743-422X-7-323
20
Yanni YN Lui, Henry LY Chan. A review of telbivudine for the management of chronic hepatitis B virus infectionExpert Opinion on Drug Metabolism & Toxicology 2008; 4(10): 1351 doi: 10.1517/17425255.4.10.1351
21
Bircan Kayaaslan, Rahmet Guner. Adverse effects of oral antiviral therapy in chronic hepatitis BWorld Journal of Hepatology 2017; 9(5): 227-241 doi: 10.4254/wjh.v9.i5.227
22
Ravindra A Prabhu, Sreekumar Nair, Ganesh Pai, Nageswara P Reddy, Deepak Suvarna. Interventions for dialysis patients with hepatitis C virus (HCV) infectionCochrane Database of Systematic Reviews 2015; 2015(8) doi: 10.1002/14651858.CD007003.pub2
23
Ming-Tsung Lin, Yi-Hao Yen, Ming-Chao Tsai, Po-Lin Tseng, Kuo-Chin Chang, Cheng-Kun Wu, Tsung-Hui Hu, Seung Up Kim. Comparison of the Efficacies and Safety of Combined Therapy between Telbivudine Plus Adefovir and Lamivudine Plus Adefovir in Patients with Hepatitis B Virus Infection in Real-World PracticePLOS ONE 2016; 11(11): e0165416 doi: 10.1371/journal.pone.0165416
24
Michèle G. DuVal, Vijaya K. Hinge, Natalie Snyder, Richard Kanyo, Jenna Bratvold, Edward Pokrishevsky, Neil R. Cashman, Nikolay Blinov, Andriy Kovalenko, W. Ted Allison. Tryptophan 32 mediates SOD1 toxicity in a in vivo motor neuron model of ALS and is a promising target for small molecule therapeuticsNeurobiology of Disease 2019; 124: 297 doi: 10.1016/j.nbd.2018.11.025
25
Eileen L. Yoon, Hyung Joon Yim, Hyun Jung Lee, Young Sun Lee, Jeong Han Kim, Eun Suk Jung, Ji Hoon Kim, Yeon Seok Seo, Jong Eun Yeon, Hong Sik Lee, Soon Ho Um, Kwan Soo Byun. Comparison of Clevudine and Entecavir for Treatment-naive Patients With Chronic Hepatitis B Virus InfectionJournal of Clinical Gastroenterology 2011; 45(10): 893 doi: 10.1097/MCG.0b013e31821f8bdf
26
Yanni YN Lui, Henry LY Chan. Treatment of chronic hepatitis B: focus on telbivudineExpert Review of Anti-infective Therapy 2009; 7(3): 259 doi: 10.1586/eri.09.6